CA2311431C - Sample detection to initiate timing of an electrochemical assay - Google Patents
Sample detection to initiate timing of an electrochemical assay Download PDFInfo
- Publication number
- CA2311431C CA2311431C CA002311431A CA2311431A CA2311431C CA 2311431 C CA2311431 C CA 2311431C CA 002311431 A CA002311431 A CA 002311431A CA 2311431 A CA2311431 A CA 2311431A CA 2311431 C CA2311431 C CA 2311431C
- Authority
- CA
- Canada
- Prior art keywords
- sample
- electrical response
- predetermined
- applying
- measuring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
Abstract
An electrochemical assay includes a method for determining with great accuracy the time at which an applied sample bridges a gap between the electrodes of an electrochemical cell. The method involves applying a constant small current across the gap, while monitoring the potential difference between the electrodes. The time at which the sample bridges the gap is marked by a sharp drop in the potential. A constant voltage is applied after the sample is detected, and the current and/or charge through the sample is monitored over a period of time. From the measured current or charge, the analyte concentration of interest can be calculated.
Description
SAMPLE DETECTION TO INITIATE TIMING OF AN ELECTROCHEMICAL
ASSAY
BACKGROUND OF THE INVENTION
1. Field of the Invention This invention relates to an electrochemical device for measuring the concentration of an analyte in a o biological fluid; more particularly, to a mechanism for determining the time at which the fluid provides an electrical connection between working and reference electrodes of the device.
is 2. Description of the Related Art A variety of medical diagnostic procedures involve tests on biological fluids, such as blood, urine, or saliva, to determine an analyte concentration in the 2o fluid. Among the analytes of greatest interest is glucose, and dry phase reagent strips incorporating enzyme-based compositions are used extensively in clinical laboratories, physicians' offices, hospitals, and homes to test samples of biological fluids for 25 glucose concentration. In fact, reagent strips have become an everyday necessity for many of the nation's - -.estimated 16 million people with diabetes. Since diabetes can cause dangerous anomalies in blood . _ ,_ chemistry, it can contribute to vision Loss, kidney failure, and other serious medical consequences. To minimize the risk of these consequences, most people with diabetes must test themselves periodically, then adjust their glucose concentration accordingly, for instance, through diet control and/or with insulin injections.
Some patients must test their blood glucose concentration as often as four times or more daily.
It is especially important for people with diabetes io who must control their diet in order to regulate sugar intake and/or administer insulin injections, and who must be guided in this regard by frequent tests of blood glucose concentration, to have a rapid, inexpensive, and accurate system for glucose determination.
One type of glucose measurement system operates electrochemically, detecting the oxidation of blood glucose on a dry reagent strip. The reagent generally includes an enzyme, such as glucose oxidase or glucose dehydrogenase, and a redox mediator, such as ferrocene or 2o ferricyanide. This type of measurement system is described in U.S. Pat. 4,224,125, issued on September 23, 1980, to Nakamura et al.; U.S. Pat. 4,545,382, issued on October 8, 1985, to Higgins et al.; and U.S. Pat.
5,266,179, issued on November 30, 1993, to Nankai et al.
Electrochemical glucose meters can be characterized -- as coulometric, amperometric, or potentiometric, depending on whether the system involves measuring charge, current, or potential, respectively, in making the determination of glucose concentration. In each case, it is important to define the point in time when the blood sample contacts the reagent, since an electrical signal must be applied to the strip at a precisely timed period thereafter.
Nankai et al., U.S. Pat. 5,266,179, issued on November 30, 1993, discloses an electrochemical system for measuring blood glucose, in which the sample o application time is defined as the time of a resistance drop between a.pair of electrodes to which a constant voltage was applied.
White et al., U.S. Pat. 5,366,609, issued on November 22, 1994, describes the same principle of monitoring the resistance drop between the electrodes to determine the time at which blood was applied to a dry glucose reagent strip. In both patents, a constant voltage is applied between working and reference electrodes to track resistance changes that result from 2o the introduction of a blood sample to a dry reagent strip.
- For accurate results, the sample detection procedure should not perturb the analyte concentration, and several techniques for minimizing analyte perturbation have been described.
Quade et al., German (DDR) Patent Application - 148,387, filed on December 28, 1979, discloses an _ electrochemical measurement that uses a novel electronic circuit, which allows rapid switching between potentiostatic (constant applied voltage) and galvanostatic (constant applied current) modes, while also allowing a reduction in the number of electronic components. A goal of the circuit is to minimize perturbation of the sample before the start of a measurement.
Bartels et al., German (DDR) Patent Application 208,230, filed on November 24, 1981, discloses an 1o electrochemical measurement that also attempts to minimize sample perturbation. The measurement device includes a circuit that uses a diode to minimize current flow before the start of the measurement, without using an additional amperometric control loop. Furthermore, the circuit switches to the potentiometric mode in a precise and rapid fashion.
Littlejohn et al., U.S. Pat. 4,940,945, issued on July 10, 1990, discloses a portable apparatus that can measure the pH. of a blood sample. The apparatus detects 2o the presence of a sample in a cell by injecting a constant current between a fill electrode outside the sample chamber and one of two electrodes inside the chamber. When the impedance decreases by at least two orders of magnitude, the meter recognizes that sufficient sample has been provided and emits a beep. The fill electrode is then cut out of the circuit that includes -- the two electrodes inside the sample cell, and measurements are made potentiometrically.
ASSAY
BACKGROUND OF THE INVENTION
1. Field of the Invention This invention relates to an electrochemical device for measuring the concentration of an analyte in a o biological fluid; more particularly, to a mechanism for determining the time at which the fluid provides an electrical connection between working and reference electrodes of the device.
is 2. Description of the Related Art A variety of medical diagnostic procedures involve tests on biological fluids, such as blood, urine, or saliva, to determine an analyte concentration in the 2o fluid. Among the analytes of greatest interest is glucose, and dry phase reagent strips incorporating enzyme-based compositions are used extensively in clinical laboratories, physicians' offices, hospitals, and homes to test samples of biological fluids for 25 glucose concentration. In fact, reagent strips have become an everyday necessity for many of the nation's - -.estimated 16 million people with diabetes. Since diabetes can cause dangerous anomalies in blood . _ ,_ chemistry, it can contribute to vision Loss, kidney failure, and other serious medical consequences. To minimize the risk of these consequences, most people with diabetes must test themselves periodically, then adjust their glucose concentration accordingly, for instance, through diet control and/or with insulin injections.
Some patients must test their blood glucose concentration as often as four times or more daily.
It is especially important for people with diabetes io who must control their diet in order to regulate sugar intake and/or administer insulin injections, and who must be guided in this regard by frequent tests of blood glucose concentration, to have a rapid, inexpensive, and accurate system for glucose determination.
One type of glucose measurement system operates electrochemically, detecting the oxidation of blood glucose on a dry reagent strip. The reagent generally includes an enzyme, such as glucose oxidase or glucose dehydrogenase, and a redox mediator, such as ferrocene or 2o ferricyanide. This type of measurement system is described in U.S. Pat. 4,224,125, issued on September 23, 1980, to Nakamura et al.; U.S. Pat. 4,545,382, issued on October 8, 1985, to Higgins et al.; and U.S. Pat.
5,266,179, issued on November 30, 1993, to Nankai et al.
Electrochemical glucose meters can be characterized -- as coulometric, amperometric, or potentiometric, depending on whether the system involves measuring charge, current, or potential, respectively, in making the determination of glucose concentration. In each case, it is important to define the point in time when the blood sample contacts the reagent, since an electrical signal must be applied to the strip at a precisely timed period thereafter.
Nankai et al., U.S. Pat. 5,266,179, issued on November 30, 1993, discloses an electrochemical system for measuring blood glucose, in which the sample o application time is defined as the time of a resistance drop between a.pair of electrodes to which a constant voltage was applied.
White et al., U.S. Pat. 5,366,609, issued on November 22, 1994, describes the same principle of monitoring the resistance drop between the electrodes to determine the time at which blood was applied to a dry glucose reagent strip. In both patents, a constant voltage is applied between working and reference electrodes to track resistance changes that result from 2o the introduction of a blood sample to a dry reagent strip.
- For accurate results, the sample detection procedure should not perturb the analyte concentration, and several techniques for minimizing analyte perturbation have been described.
Quade et al., German (DDR) Patent Application - 148,387, filed on December 28, 1979, discloses an _ electrochemical measurement that uses a novel electronic circuit, which allows rapid switching between potentiostatic (constant applied voltage) and galvanostatic (constant applied current) modes, while also allowing a reduction in the number of electronic components. A goal of the circuit is to minimize perturbation of the sample before the start of a measurement.
Bartels et al., German (DDR) Patent Application 208,230, filed on November 24, 1981, discloses an 1o electrochemical measurement that also attempts to minimize sample perturbation. The measurement device includes a circuit that uses a diode to minimize current flow before the start of the measurement, without using an additional amperometric control loop. Furthermore, the circuit switches to the potentiometric mode in a precise and rapid fashion.
Littlejohn et al., U.S. Pat. 4,940,945, issued on July 10, 1990, discloses a portable apparatus that can measure the pH. of a blood sample. The apparatus detects 2o the presence of a sample in a cell by injecting a constant current between a fill electrode outside the sample chamber and one of two electrodes inside the chamber. When the impedance decreases by at least two orders of magnitude, the meter recognizes that sufficient sample has been provided and emits a beep. The fill electrode is then cut out of the circuit that includes -- the two electrodes inside the sample cell, and measurements are made potentiometrically.
SUN~IARY OF THE INVENTION
The present invention provides a method for measuring an analyte concentration in a sample of a biological fluid that is applied to an electrochemical diagnostic strip of the type that includes juxtaposed working and reference electrodes. The method comprises:
(a) applying a predetermined, constant current 1o source between the working and reference electrodes, (b) monitoring a potential difference across the electrodes, (c) applying the sample to the strip, (d) determining a sample detection time by noting when the potential difference falls below a predetermined threshold voltage, (e) applying a predetermined constant voltage to the sample, (f) measuring an electrical response at a 2a predetermined time after applying the constant voltage, and (g) calculating the analyte concentration, using the measured electrical response.
A meter for measuring an analyte concentration in a sample of a biological fluid that has been applied to a diagnostic strip comprises, in electrical communication, -_ (a) means for applying a predetermined current between the working and references electrodes, (b) means for monitoring a potential difference across the electrodes, (c) means for determining when the potential difference falls below a predetermined threshold voltage s to indicate sample detection, (d) means responsive to sample detection for applying a predetermined constant voltage to the sample, (e) means for measuring a resulting electrical response, and (f) means for calculating the analyte concentration by using the measured electrical response.
The present invention provides a method and apparatus for measuring analyte concentration electrochemically, which includes defining with great 1s accuracy the time at which a sample that is applied to the reaction zone of an electrochemical diagnostic strip bridges the gap between the electrodes. Determining the sample application time (more precisely, the sample detection time; we use the terms interchangeably) 2o accurately permits greater accuracy and precision of the assay done on the sample.
- An advantage of the present method for determining sample application time is that applying a constant, small current for detecting sample minimizes sample zs perturbation, compared with prior art methods that applied a constant voltage. Using the latter approach, -- applying a sample causes a current that exceeds a defined threshold to initiate timing. Since the sampling rate is _ 7 _ limited, the current will typically be substantial, before the sensor recognizes that the threshold has been exceeded. When a large current is observed, a correspondingly large perturbation in the mediator is observed. This could lead to an inaccurate measurement, especially at low analyte concentrations.
The prior art method of applying a constant potential to detect sample application has another disadvantage in that the initial current generally io decreases with decreasing analyte concentration. Thus it is more difficult to determine an initial sample detection time for low-analyte samples. By the same token, if the current threshold is set too low, it can be falsely triggered by noise. To further complicate matters, the presence of a high concentration of red blood cells also decreases the initial current.
Analyte and red blood cell concentrations do not affect the method of the present invention. Likewise, noise is not a significant problem either, because the 2o detection trigger is a large change in signal voltage.
- BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a graph of applied current and measured voltage vs. time that depicts the sample-detection process of the present invention.
_ g _ Fig. 2 is a graph of applied voltage and resulting current response vs. time for an assay method of the present invention.
Fig. 3 is a graph of applied voltage and current response vs. time for an alternative assay method of the present invention.
Fig. 4 is a graph of charge vs. time for another alternative assay method of the present invention.
Fig. 5 depicts an electrochemical device suitable for use 1o in the assay method of the present invention.
Fig. 6 is a diagram of a circuit suitable for use in the present invention.
DETAILED DESCRIPTION OF THE INVENTION
This invention relates to an electrochemical method of measuring an analyte concentration in a biological fluid. In the interest of brevity, the description below emphasizes measuring glucose concentration in samples of 2o whole blood; however,, the person of ordinary skill in the medical diagnostics.art will recognize how the description can be adapted to monitor other analytes (such as cholesterol, ketone bodies, alcohol, etc.) in other fluids (such as saliva, urine, interstitial fluid, etc.) The electrochemical (amperometric) method for _ . measuring an analyte concentration in an aqueous sample involves placing the sample into a reaction zone in an _ g _ electrochemical cell that has two electrodes having an impedance that is suitable for the amperometric measurement. The analyte is allowed to react directly with an electrode or with a redox reagent to form an oxidizable (or reducible) substance in an amount that corresponds to the analyte concentration. The quantity of oxidizable (or reducible) substance is then determined electrochemically. This type of assay must accurately define the point in time at which the sample is detected 1o in the reaction zone. This permits an electrochemical waveform (i.e., voltage) to be applied immediately after the sample has been applied and accurately defines an incubation period or reaction time. In turn, this improves the accuracy and precision of the assay, as described below.
The present invention provides an improved method and apparatus far determining the sample detection time.
The method involves applying a small, constant current source across the electrode of an electrochemical 2o diagnostic strip and monitoring the potential difference between the electrodes. Since there is a dry gap between .- the electrodes, negligible current flows initially. When sample is applied to the strip and fills the gap, the measured voltage decreases rapidly, 'causing the test time 2s to be initiated. On thus recognizing that sample has been applied, the apparatus switches from a constant -~ current to constant voltage mode. In the constant voltage mode, either current or charge are measured as a function of time to permit the analyte concentration to be calculated. This technique minimizes the error introduced into signal response by the timing-initiation circuit and thereby enables low detection limits. The electronic components are simple and inexpensive.
Fig. 1 is a plot of applied current and measured voltage that depicts the sample-detection process of the present invention. Prior to time zero (i.e., before sample is introduced), a constant (here, for example 1 ~.~A) current is applied between the electrodes, but negligible current flows. Smaller current reduces perturbation and is preferred, particularly for small analyte concentration. The measured voltage is determined by the circuit power supply voltage - in this 1s case, 5 volts. When the sample is introduced into the cell (at time zero), the applied current can flow between the electrodes and the measured voltage falls rapidly.
When the voltage falls below a threshold voltage, the device switches from constant applied current to constant 20_ applied voltage.
. Fig. 2 is a graph that depicts the applied potential and measured current as a function of time after sample detection. Sample is detected at time t=0, and a voltage is applied between the working and counter electrodes 25 immediately thereafter. As a result, current flows between the electrodes. The current after a predetermined -- time is a measure of the analyte concentration, once the system has been calibrated, using samples having known analyte concentrations. The duration of the predetermined time is not critical. It is generally at least about 3 seconds when the fluid is blood and the analyte is glucose. That duration generally provides sufficient time to dissolve reagents and reduce an amount of mediator that is readily measurable. All things being equal, at high hematocrit, longer times are needed.
Practically speaking, a user is generally interested in having a reading as soon as possible. Ten seconds 1o duration is typically satisfactory, with no motivation to wait longer. Of course, once a predetermined time is set, accurate and precise results require that the same time be used each time. In any case, the accuracy of the current determination depends on the accuracy of the t=0 determination.
Fig. 3 depicts a graph of the measured current and applied voltage vs. time in an alternative method. In this method, a second voltage pulse is applied across the electrodes after the predetermined time. Generally, the 2o second pulse is applied immediately after the predetermined time (to minimize the total measurement .. time), but a delay is permissible. Again, reproducible results require reproducible procedures; thus, in this method as well, it is important to determine accurately the t=0 point. The second pulse causes a positive spike in the current through the electrodes, followed by a -w decaying current. The analyte concentration can, after the system has been calibrated, be determined from the decay rate, either alone or in combination with the current measurement depicted in Fig. 2. Generally, the current decays exponentially over a period that begins about 1 second after the second pulse is applied and continues for at least several seconds thereafter.
Fig. 4 depicts the method of Fig. 3 in which charge, rather than current, was measured. As with the graph of Fig. 3, analyte concentration can be determined from the total charge at a fixed time and/or from the decay rate 1o after the second voltage is applied.
Fig. 5 depicts a "thin layer" device 10 that is suitable for use in the methods described above.
Substrate 12 is a polyester base 14 on which has been deposited - typically, by sputtering - a Pd coating 16, which forms the working electrode. A dry reagent, consisting of buffer, mediator, and enzyme, is deposited near one end 18 of the electrode. Spacing layer 20 is double-sided adhesive having a cutout 22 that defines the electrochemical cell. Typically the spacer is less than 2o about 200 Etm thick. Top layer 24 is polyester layer 26 on which has been deposited - typically by sputtering, also - a Au coating 28, which forms the reference electrode.
A device of the type described above can use a "_glucose oxidase (GOD)/ferricyanide system to determine glucose concentrations via the following reactions, in -which GOD* is the reduced enzyme.
Reaction 1 glucose + GOD -~ gluconic acid + GOD*
Reaction 2 GOD* + 2ferricyanide --+ GOD + 2ferrocyanide.
Ferricyanide ([Fe(CN)6]3-) is the mediator, which returns the GOD* to its catalytic state. GOD, an enzyme catalyst, will continue to oxidize glucose so long as io excess mediator is present. Ferrocyanide ([Fe(CN)6]4-) is the product of the total reaction. Ideally, there is no ferrocyanide initially, although in practice there is often a small quantity. After the reaction is complete, the concentration of ferrocyanide (measured electrochemically) indicates the initial concentration of glucose. The total reaction is the sum of reactions 1 and 2.
Reaction 3 ~p _ glucose + 2ferricyanide ~ gluconic acid + 2ferrocyanide "Glucose" refers specifically to ~i-D-glucose.
Details of this system are described in PCT
application no. WO 97/18465, incorporated herein by reference.
Fig. 6 depicts an embodiment of suitable circuitry to practice this invention. Initially, a constant current source is applied to the strips with switch 105 in position 1. The current source consists of operational amplifier 104, voltage reference 102, and resistors 101 and 103. The current is determined by the ratio of voltage reference 102 to resistor 103. Resistor 101 is used to generate the required bias. Operational amplifier 110 and resistor 109 are used as a current-to-voltage converter. Initially, with no sample on the strip, the resistance between points 107 and 108 is very , large, and the current passing through the strip is negligible. The output voltage of operational amplifier 104(V1) is high in this condition. When a sample is applied to the strip, its resistance drops significantly and, since a constant current flows through the strip, V1 drops. V1 is fed to microprocessor 112 through analog to-digital converter 111. Microprocessor 112, recognizing this reduced voltage as sample detection, switches 105 to position 2 to disconnect the strip from the current source and connect it to the voltage source 106. In this condition, a chronoamperometric measurement can be achieved by measuring the output voltage of the operational amplifier 110 (V2). This voltage is proportional to the current passing through the strip.
The following Example demonstrates the present invention but is not intended to be in any way limiting.
Example The circuit of Fig. 6 was established, with strip S
being a thin layer electrochemical glucose strip of the type shown in Fig. 5, having Pd and Au electrodes. The Pd electrode was coated with a layer of buffer, glucose dehydrogenase (PQQ), and ferricyanide. A constant, small (-1 ~A) non-perturbing current was applied between the working electrode and counter/reference electrode of the dry glucose strip. Because the strip was dry, the resistance between the working and counter/reference electrode was essentially infinite. After a whole-blood sample was applied across the cell, a drop in voltage was observed. A threshold of about 50 to 500 mV initiated the start time (a threshold of about 300 mV is preferred).
After sample was detected, the instrument switched from applying a constant current to applying a constant voltage. Measurement of the current through the sample as a function of time permitted the glucose concentration to be calculated.
It will be understood by those skilled in the art 2o that the foregoing description and Example are illustrative of practicing the present invention, but are in no way limiting. Variations of the detail presented ,_ herein may be made, without departing from the scope and spirit of the present invention.
The present invention provides a method for measuring an analyte concentration in a sample of a biological fluid that is applied to an electrochemical diagnostic strip of the type that includes juxtaposed working and reference electrodes. The method comprises:
(a) applying a predetermined, constant current 1o source between the working and reference electrodes, (b) monitoring a potential difference across the electrodes, (c) applying the sample to the strip, (d) determining a sample detection time by noting when the potential difference falls below a predetermined threshold voltage, (e) applying a predetermined constant voltage to the sample, (f) measuring an electrical response at a 2a predetermined time after applying the constant voltage, and (g) calculating the analyte concentration, using the measured electrical response.
A meter for measuring an analyte concentration in a sample of a biological fluid that has been applied to a diagnostic strip comprises, in electrical communication, -_ (a) means for applying a predetermined current between the working and references electrodes, (b) means for monitoring a potential difference across the electrodes, (c) means for determining when the potential difference falls below a predetermined threshold voltage s to indicate sample detection, (d) means responsive to sample detection for applying a predetermined constant voltage to the sample, (e) means for measuring a resulting electrical response, and (f) means for calculating the analyte concentration by using the measured electrical response.
The present invention provides a method and apparatus for measuring analyte concentration electrochemically, which includes defining with great 1s accuracy the time at which a sample that is applied to the reaction zone of an electrochemical diagnostic strip bridges the gap between the electrodes. Determining the sample application time (more precisely, the sample detection time; we use the terms interchangeably) 2o accurately permits greater accuracy and precision of the assay done on the sample.
- An advantage of the present method for determining sample application time is that applying a constant, small current for detecting sample minimizes sample zs perturbation, compared with prior art methods that applied a constant voltage. Using the latter approach, -- applying a sample causes a current that exceeds a defined threshold to initiate timing. Since the sampling rate is _ 7 _ limited, the current will typically be substantial, before the sensor recognizes that the threshold has been exceeded. When a large current is observed, a correspondingly large perturbation in the mediator is observed. This could lead to an inaccurate measurement, especially at low analyte concentrations.
The prior art method of applying a constant potential to detect sample application has another disadvantage in that the initial current generally io decreases with decreasing analyte concentration. Thus it is more difficult to determine an initial sample detection time for low-analyte samples. By the same token, if the current threshold is set too low, it can be falsely triggered by noise. To further complicate matters, the presence of a high concentration of red blood cells also decreases the initial current.
Analyte and red blood cell concentrations do not affect the method of the present invention. Likewise, noise is not a significant problem either, because the 2o detection trigger is a large change in signal voltage.
- BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a graph of applied current and measured voltage vs. time that depicts the sample-detection process of the present invention.
_ g _ Fig. 2 is a graph of applied voltage and resulting current response vs. time for an assay method of the present invention.
Fig. 3 is a graph of applied voltage and current response vs. time for an alternative assay method of the present invention.
Fig. 4 is a graph of charge vs. time for another alternative assay method of the present invention.
Fig. 5 depicts an electrochemical device suitable for use 1o in the assay method of the present invention.
Fig. 6 is a diagram of a circuit suitable for use in the present invention.
DETAILED DESCRIPTION OF THE INVENTION
This invention relates to an electrochemical method of measuring an analyte concentration in a biological fluid. In the interest of brevity, the description below emphasizes measuring glucose concentration in samples of 2o whole blood; however,, the person of ordinary skill in the medical diagnostics.art will recognize how the description can be adapted to monitor other analytes (such as cholesterol, ketone bodies, alcohol, etc.) in other fluids (such as saliva, urine, interstitial fluid, etc.) The electrochemical (amperometric) method for _ . measuring an analyte concentration in an aqueous sample involves placing the sample into a reaction zone in an _ g _ electrochemical cell that has two electrodes having an impedance that is suitable for the amperometric measurement. The analyte is allowed to react directly with an electrode or with a redox reagent to form an oxidizable (or reducible) substance in an amount that corresponds to the analyte concentration. The quantity of oxidizable (or reducible) substance is then determined electrochemically. This type of assay must accurately define the point in time at which the sample is detected 1o in the reaction zone. This permits an electrochemical waveform (i.e., voltage) to be applied immediately after the sample has been applied and accurately defines an incubation period or reaction time. In turn, this improves the accuracy and precision of the assay, as described below.
The present invention provides an improved method and apparatus far determining the sample detection time.
The method involves applying a small, constant current source across the electrode of an electrochemical 2o diagnostic strip and monitoring the potential difference between the electrodes. Since there is a dry gap between .- the electrodes, negligible current flows initially. When sample is applied to the strip and fills the gap, the measured voltage decreases rapidly, 'causing the test time 2s to be initiated. On thus recognizing that sample has been applied, the apparatus switches from a constant -~ current to constant voltage mode. In the constant voltage mode, either current or charge are measured as a function of time to permit the analyte concentration to be calculated. This technique minimizes the error introduced into signal response by the timing-initiation circuit and thereby enables low detection limits. The electronic components are simple and inexpensive.
Fig. 1 is a plot of applied current and measured voltage that depicts the sample-detection process of the present invention. Prior to time zero (i.e., before sample is introduced), a constant (here, for example 1 ~.~A) current is applied between the electrodes, but negligible current flows. Smaller current reduces perturbation and is preferred, particularly for small analyte concentration. The measured voltage is determined by the circuit power supply voltage - in this 1s case, 5 volts. When the sample is introduced into the cell (at time zero), the applied current can flow between the electrodes and the measured voltage falls rapidly.
When the voltage falls below a threshold voltage, the device switches from constant applied current to constant 20_ applied voltage.
. Fig. 2 is a graph that depicts the applied potential and measured current as a function of time after sample detection. Sample is detected at time t=0, and a voltage is applied between the working and counter electrodes 25 immediately thereafter. As a result, current flows between the electrodes. The current after a predetermined -- time is a measure of the analyte concentration, once the system has been calibrated, using samples having known analyte concentrations. The duration of the predetermined time is not critical. It is generally at least about 3 seconds when the fluid is blood and the analyte is glucose. That duration generally provides sufficient time to dissolve reagents and reduce an amount of mediator that is readily measurable. All things being equal, at high hematocrit, longer times are needed.
Practically speaking, a user is generally interested in having a reading as soon as possible. Ten seconds 1o duration is typically satisfactory, with no motivation to wait longer. Of course, once a predetermined time is set, accurate and precise results require that the same time be used each time. In any case, the accuracy of the current determination depends on the accuracy of the t=0 determination.
Fig. 3 depicts a graph of the measured current and applied voltage vs. time in an alternative method. In this method, a second voltage pulse is applied across the electrodes after the predetermined time. Generally, the 2o second pulse is applied immediately after the predetermined time (to minimize the total measurement .. time), but a delay is permissible. Again, reproducible results require reproducible procedures; thus, in this method as well, it is important to determine accurately the t=0 point. The second pulse causes a positive spike in the current through the electrodes, followed by a -w decaying current. The analyte concentration can, after the system has been calibrated, be determined from the decay rate, either alone or in combination with the current measurement depicted in Fig. 2. Generally, the current decays exponentially over a period that begins about 1 second after the second pulse is applied and continues for at least several seconds thereafter.
Fig. 4 depicts the method of Fig. 3 in which charge, rather than current, was measured. As with the graph of Fig. 3, analyte concentration can be determined from the total charge at a fixed time and/or from the decay rate 1o after the second voltage is applied.
Fig. 5 depicts a "thin layer" device 10 that is suitable for use in the methods described above.
Substrate 12 is a polyester base 14 on which has been deposited - typically, by sputtering - a Pd coating 16, which forms the working electrode. A dry reagent, consisting of buffer, mediator, and enzyme, is deposited near one end 18 of the electrode. Spacing layer 20 is double-sided adhesive having a cutout 22 that defines the electrochemical cell. Typically the spacer is less than 2o about 200 Etm thick. Top layer 24 is polyester layer 26 on which has been deposited - typically by sputtering, also - a Au coating 28, which forms the reference electrode.
A device of the type described above can use a "_glucose oxidase (GOD)/ferricyanide system to determine glucose concentrations via the following reactions, in -which GOD* is the reduced enzyme.
Reaction 1 glucose + GOD -~ gluconic acid + GOD*
Reaction 2 GOD* + 2ferricyanide --+ GOD + 2ferrocyanide.
Ferricyanide ([Fe(CN)6]3-) is the mediator, which returns the GOD* to its catalytic state. GOD, an enzyme catalyst, will continue to oxidize glucose so long as io excess mediator is present. Ferrocyanide ([Fe(CN)6]4-) is the product of the total reaction. Ideally, there is no ferrocyanide initially, although in practice there is often a small quantity. After the reaction is complete, the concentration of ferrocyanide (measured electrochemically) indicates the initial concentration of glucose. The total reaction is the sum of reactions 1 and 2.
Reaction 3 ~p _ glucose + 2ferricyanide ~ gluconic acid + 2ferrocyanide "Glucose" refers specifically to ~i-D-glucose.
Details of this system are described in PCT
application no. WO 97/18465, incorporated herein by reference.
Fig. 6 depicts an embodiment of suitable circuitry to practice this invention. Initially, a constant current source is applied to the strips with switch 105 in position 1. The current source consists of operational amplifier 104, voltage reference 102, and resistors 101 and 103. The current is determined by the ratio of voltage reference 102 to resistor 103. Resistor 101 is used to generate the required bias. Operational amplifier 110 and resistor 109 are used as a current-to-voltage converter. Initially, with no sample on the strip, the resistance between points 107 and 108 is very , large, and the current passing through the strip is negligible. The output voltage of operational amplifier 104(V1) is high in this condition. When a sample is applied to the strip, its resistance drops significantly and, since a constant current flows through the strip, V1 drops. V1 is fed to microprocessor 112 through analog to-digital converter 111. Microprocessor 112, recognizing this reduced voltage as sample detection, switches 105 to position 2 to disconnect the strip from the current source and connect it to the voltage source 106. In this condition, a chronoamperometric measurement can be achieved by measuring the output voltage of the operational amplifier 110 (V2). This voltage is proportional to the current passing through the strip.
The following Example demonstrates the present invention but is not intended to be in any way limiting.
Example The circuit of Fig. 6 was established, with strip S
being a thin layer electrochemical glucose strip of the type shown in Fig. 5, having Pd and Au electrodes. The Pd electrode was coated with a layer of buffer, glucose dehydrogenase (PQQ), and ferricyanide. A constant, small (-1 ~A) non-perturbing current was applied between the working electrode and counter/reference electrode of the dry glucose strip. Because the strip was dry, the resistance between the working and counter/reference electrode was essentially infinite. After a whole-blood sample was applied across the cell, a drop in voltage was observed. A threshold of about 50 to 500 mV initiated the start time (a threshold of about 300 mV is preferred).
After sample was detected, the instrument switched from applying a constant current to applying a constant voltage. Measurement of the current through the sample as a function of time permitted the glucose concentration to be calculated.
It will be understood by those skilled in the art 2o that the foregoing description and Example are illustrative of practicing the present invention, but are in no way limiting. Variations of the detail presented ,_ herein may be made, without departing from the scope and spirit of the present invention.
Claims (15)
1. A method for measuring an analyte concentration in a sample of a biological fluid that is applied to an electrochemical diagnostic strip of the type that includes juxtaposed working and reference electrodes comprising (a) applying a predetermined, constant current source between the working and reference electrodes, (b) monitoring a potential difference across the electrodes, (c) applying the sample to the strip, (d) determining a sample detection time by noting when the potential difference falls below a predetermined threshold voltage, e) applying a predetermined constant voltage to the sample, (f) measuring an electrical response at a predetermined time after applying the constant voltage, and (g) calculating the analyte concentration using the measured electrical response.
2. The method of claim 1 in which the electrical response measured is current through the sample at the predetermined time.
3. The method of claim 1 in which the electrical response measured is charge passing through the sample from the sample detection time to the predetermined time.
4. The method of claim 1, further comprising applying a second predetermined voltage after the predetermined time and measuring a second electrical response after applying the second predetermined voltage.
5. The method of claim 4 in which the second electrical response is a rate of decay of current through the sample.
6. The method of claim 4 in which the second electrical response is charge passing through the sample during a predetermined time interval after the second voltage is applied.
7. A meter for measuring an analyte concentration in a sample of a biological fluid that has been applied between a working and reference electrode of a diagnostic strip comprising, in electrical communication, (a) means for applying a predetermined current between the working and reference electrodes, (b) means for monitoring a potential difference across the electrodes, (c) means for determining when the potential difference falls below a predetermined threshold voltage to indicate sample detection, (d) means responsive to sample detection for applying a predetermined constant voltage to the sample, (e) means for measuring a resulting electrical response, and (f) means for calculating the analyte concentration by using the measured electrical response.
8. The meter of claim 7 in which the means for measuring a resulting electrical response is an ammeter.
9. The meter of claim 7 in which the means for measuring a resulting electrical response is a coulometer.
10. The meter of claim 7 further comprising means for applying a second predetermined voltage to the sample and means for measuring a second resulting electrical response.
11. The meter of claim 10 in which the means for measuring a second resulting electrical response is an ammeter.
12. The meter of claim 10 in which the means for measuring a second resulting electrical response is a coulometer.
13. A method for measuring an analyte concentration in a sample of a biological fluid that is applied to an electrochemical diagnostic strip of the type that includes juxtaposed working and reference electrodes comprising (a) applying a predetermined, constant current source between the working and reference electrodes, (b) monitoring a potential difference across the electrodes, (c) applying the sample to the strip, (d) determining a sample detection time by noting when the potential difference falls below a predetermined threshold voltage, e) applying a predetermined constant voltage to the sample, (f) applying a second predetermined voltage to the sample after a first predetermined time, (g) measuring an electrical response at a predetermined time after the first predetermined time, and (h) calculating the analyte concentration using the measured electrical response.
14. The method of claim 13 in which the electrical response measured is a rate of decay of current through the sample.
15. The method of claim 13 in which the electrical response measured is the charge passing through the sample during a predetermined time interval after the second predetermined voltage is applied.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/333,793 | 1999-06-15 | ||
| US09/333,793 US6193873B1 (en) | 1999-06-15 | 1999-06-15 | Sample detection to initiate timing of an electrochemical assay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2311431A1 CA2311431A1 (en) | 2000-12-15 |
| CA2311431C true CA2311431C (en) | 2007-03-27 |
Family
ID=23304277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002311431A Expired - Lifetime CA2311431C (en) | 1999-06-15 | 2000-06-13 | Sample detection to initiate timing of an electrochemical assay |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6193873B1 (en) |
| EP (1) | EP1067384B1 (en) |
| JP (1) | JP4573400B2 (en) |
| KR (1) | KR100712380B1 (en) |
| CN (1) | CN1160563C (en) |
| AR (1) | AR024351A1 (en) |
| AT (1) | ATE256869T1 (en) |
| AU (1) | AU761438B2 (en) |
| BR (1) | BRPI0002963B8 (en) |
| CA (1) | CA2311431C (en) |
| DE (1) | DE60007229T2 (en) |
| DK (1) | DK1067384T3 (en) |
| ES (1) | ES2212969T3 (en) |
| HK (2) | HK1032820A1 (en) |
| HU (1) | HUP0002275A3 (en) |
| ID (1) | ID26387A (en) |
| IL (1) | IL136700A (en) |
| MY (1) | MY126044A (en) |
| NO (1) | NO20003045L (en) |
| PT (1) | PT1067384E (en) |
| RU (1) | RU2238548C2 (en) |
| SG (1) | SG80681A1 (en) |
| TW (1) | TW510970B (en) |
Families Citing this family (245)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413410B1 (en) * | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
| AUPN661995A0 (en) | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| US6863801B2 (en) * | 1995-11-16 | 2005-03-08 | Lifescan, Inc. | Electrochemical cell |
| US7407811B2 (en) * | 1997-12-22 | 2008-08-05 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC excitation |
| US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
| US7390667B2 (en) * | 1997-12-22 | 2008-06-24 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC phase angle measurements |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| DE19936693A1 (en) * | 1999-08-04 | 2001-02-08 | Lre Technology Partner Gmbh | Instrument for the measurement of blood sugar concentrations has a test field with electrodes for the test strip and a circuit for measurement/evaluation of the current strength for display |
| US7276146B2 (en) * | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| US20050103624A1 (en) * | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| KR100340173B1 (en) | 2000-03-22 | 2002-06-12 | 이동준 | Electrochemical Biosensor Readout Meter |
| US6488827B1 (en) * | 2000-03-31 | 2002-12-03 | Lifescan, Inc. | Capillary flow control in a medical diagnostic device |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US6620310B1 (en) * | 2000-12-13 | 2003-09-16 | Lifescan, Inc. | Electrochemical coagulation assay and device |
| US7144495B2 (en) * | 2000-12-13 | 2006-12-05 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
| US6562625B2 (en) * | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| ATE485766T1 (en) | 2001-06-12 | 2010-11-15 | Pelikan Technologies Inc | ELECTRICAL ACTUATING ELEMENT FOR A LANCET |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US6875613B2 (en) | 2001-06-12 | 2005-04-05 | Lifescan, Inc. | Biological fluid constituent sampling and measurement devices and methods |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| DE60234598D1 (en) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES |
| US20030036202A1 (en) | 2001-08-01 | 2003-02-20 | Maria Teodorcyzk | Methods and devices for use in analyte concentration determination assays |
| US20030028125A1 (en) | 2001-08-06 | 2003-02-06 | Yuzhakov Vadim V. | Physiological sample collection devices and methods of using the same |
| ATE505724T1 (en) | 2001-09-14 | 2011-04-15 | Arkray Inc | METHOD, APPARATUS AND APPARATUS FOR CONCENTRATION MEASUREMENT |
| US6797150B2 (en) * | 2001-10-10 | 2004-09-28 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| CN1920548B (en) * | 2001-10-10 | 2013-05-29 | 生命扫描有限公司 | Method for manufacturing electrochemical cell |
| AU2002356956A1 (en) * | 2001-11-16 | 2003-06-10 | North Carolina State University | Biomedical electrochemical sensor array and method of fabrication |
| US20030116447A1 (en) * | 2001-11-16 | 2003-06-26 | Surridge Nigel A. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| US6749887B1 (en) * | 2001-11-28 | 2004-06-15 | Lifescan, Inc. | Solution drying system |
| US6872299B2 (en) * | 2001-12-10 | 2005-03-29 | Lifescan, Inc. | Passive sample detection to initiate timing of an assay |
| US6856125B2 (en) * | 2001-12-12 | 2005-02-15 | Lifescan, Inc. | Biosensor apparatus and method with sample type and volume detection |
| US6872358B2 (en) | 2002-01-16 | 2005-03-29 | Lifescan, Inc. | Test strip dispenser |
| US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
| US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
| US20030212379A1 (en) * | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
| US20030186446A1 (en) | 2002-04-02 | 2003-10-02 | Jerry Pugh | Test strip containers and methods of using the same |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US20080112852A1 (en) * | 2002-04-25 | 2008-05-15 | Neel Gary T | Test Strips and System for Measuring Analyte Levels in a Fluid Sample |
| US6743635B2 (en) * | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
| US6946299B2 (en) * | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US6964871B2 (en) * | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
| US7343188B2 (en) * | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
| US7291256B2 (en) * | 2002-09-12 | 2007-11-06 | Lifescan, Inc. | Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays |
| US9017544B2 (en) | 2002-10-04 | 2015-04-28 | Roche Diagnostics Operations, Inc. | Determining blood glucose in a small volume sample receiving cavity and in a short time period |
| US7118916B2 (en) * | 2002-10-21 | 2006-10-10 | Lifescan, Inc. | Method of reducing analysis time of endpoint-type reaction profiles |
| US20050049522A1 (en) * | 2002-10-30 | 2005-03-03 | Allen John J | Method of lancing skin for the extraction of blood |
| US20040120848A1 (en) * | 2002-12-20 | 2004-06-24 | Maria Teodorczyk | Method for manufacturing a sterilized and calibrated biosensor-based medical device |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
| US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
| US7120483B2 (en) * | 2003-01-13 | 2006-10-10 | Isense Corporation | Methods for analyte sensing and measurement |
| CA2455669A1 (en) * | 2003-02-04 | 2004-08-04 | Bayer Healthcare, Llc | Method and test strip for determining glucose in blood |
| US7132041B2 (en) * | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| US7033541B2 (en) | 2003-03-25 | 2006-04-25 | Bell Thomas W | Bicarbonate receptor compounds |
| US20040193202A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Integrated lance and strip for analyte measurement |
| US20040193072A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Method of analyte measurement using integrated lance and strip |
| US7473264B2 (en) * | 2003-03-28 | 2009-01-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
| US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
| EP1628567B1 (en) | 2003-05-30 | 2010-08-04 | Pelikan Technologies Inc. | Method and apparatus for fluid injection |
| DK1633235T3 (en) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparatus for sampling body fluid and detecting analyte |
| US8066639B2 (en) * | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US7645373B2 (en) * | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
| US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
| US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| US7597793B2 (en) * | 2003-06-20 | 2009-10-06 | Roche Operations Ltd. | System and method for analyte measurement employing maximum dosing time delay |
| US8679853B2 (en) * | 2003-06-20 | 2014-03-25 | Roche Diagnostics Operations, Inc. | Biosensor with laser-sealed capillary space and method of making |
| US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
| US7645421B2 (en) * | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
| ES2657627T3 (en) * | 2003-06-20 | 2018-03-06 | F. Hoffmann-La Roche Ag | Electrochemical biosensors |
| PT1639352T (en) | 2003-06-20 | 2018-07-09 | Hoffmann La Roche | Method and reagent for producing narrow, homogenous reagent strips |
| US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
| US8071030B2 (en) * | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
| US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
| US7220034B2 (en) * | 2003-07-11 | 2007-05-22 | Rudolph Technologies, Inc. | Fiber optic darkfield ring light |
| US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
| EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
| WO2005040784A1 (en) * | 2003-10-29 | 2005-05-06 | Arkray, Inc. | Specimen analysis method and specimen analysis device |
| ES2739529T3 (en) * | 2003-11-06 | 2020-01-31 | Lifescan Inc | Drug administration pen with event notification means |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
| EP1713926B1 (en) | 2004-02-06 | 2012-08-01 | Bayer HealthCare, LLC | Oxidizable species as an internal reference for biosensors and method of use |
| US20050187525A1 (en) * | 2004-02-19 | 2005-08-25 | Hilgers Michael E. | Devices and methods for extracting bodily fluid |
| DE102004013699A1 (en) * | 2004-03-18 | 2005-10-06 | Tesa Ag | Pressure-sensitive adhesive tape for medical diagnostic strips |
| US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
| EP1756557B1 (en) | 2004-05-21 | 2017-03-15 | Agamatrix, Inc. | Method of making an electrochemical cell |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
| US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
| US7556723B2 (en) * | 2004-06-18 | 2009-07-07 | Roche Diagnostics Operations, Inc. | Electrode design for biosensor |
| US20050284757A1 (en) * | 2004-06-29 | 2005-12-29 | Allen John J | Analyte measuring system which prevents the reuse of a test strip |
| US20050284773A1 (en) | 2004-06-29 | 2005-12-29 | Allen John J | Method of preventing reuse in an analyte measuring system |
| US8343074B2 (en) | 2004-06-30 | 2013-01-01 | Lifescan Scotland Limited | Fluid handling devices |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
| US8016154B2 (en) * | 2005-05-25 | 2011-09-13 | Lifescan, Inc. | Sensor dispenser device and method of use |
| US8192599B2 (en) * | 2005-05-25 | 2012-06-05 | Universal Biosensors Pty Ltd | Method and apparatus for electrochemical analysis |
| US8323464B2 (en) * | 2005-05-25 | 2012-12-04 | Universal Biosensors Pty Ltd | Method and apparatus for electrochemical analysis |
| US7695600B2 (en) | 2005-06-03 | 2010-04-13 | Hypoguard Limited | Test system |
| KR101321296B1 (en) | 2005-07-20 | 2013-10-28 | 바이엘 헬스케어 엘엘씨 | Gated amperometry temperature determination |
| US7749371B2 (en) | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
| EP1928304B1 (en) | 2005-09-30 | 2012-10-24 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
| US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| JP5671205B2 (en) | 2005-09-30 | 2015-02-18 | バイエル・ヘルスケア・エルエルシー | Gated voltammetry |
| US8057404B2 (en) * | 2005-10-12 | 2011-11-15 | Panasonic Corporation | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
| US7468125B2 (en) | 2005-10-17 | 2008-12-23 | Lifescan, Inc. | System and method of processing a current sample for calculating a glucose concentration |
| US8066866B2 (en) | 2005-10-17 | 2011-11-29 | Lifescan, Inc. | Methods for measuring physiological fluids |
| US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
| US7955484B2 (en) * | 2005-12-14 | 2011-06-07 | Nova Biomedical Corporation | Glucose biosensor and method |
| US7774038B2 (en) * | 2005-12-30 | 2010-08-10 | Medtronic Minimed, Inc. | Real-time self-calibrating sensor system and method |
| US8529751B2 (en) | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
| US8163162B2 (en) * | 2006-03-31 | 2012-04-24 | Lifescan, Inc. | Methods and apparatus for analyzing a sample in the presence of interferents |
| US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
| US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
| WO2007143225A2 (en) | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
| EP1909096A1 (en) * | 2006-10-04 | 2008-04-09 | Infopia Co., Ltd. | Biosensor |
| US7655120B2 (en) | 2006-10-11 | 2010-02-02 | Infopia Co., Ltd. | Biosensor |
| CN101162213B (en) * | 2006-10-13 | 2012-03-07 | 因福皮亚有限公司 | Biologic sensor |
| US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
| US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
| US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
| US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
| US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US7794658B2 (en) * | 2007-07-25 | 2010-09-14 | Lifescan, Inc. | Open circuit delay devices, systems, and methods for analyte measurement |
| US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
| US8001825B2 (en) * | 2007-11-30 | 2011-08-23 | Lifescan, Inc. | Auto-calibrating metering system and method of use |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| US8097674B2 (en) * | 2007-12-31 | 2012-01-17 | Bridgestone Corporation | Amino alkoxy-modified silsesquioxanes in silica-filled rubber with low volatile organic chemical evolution |
| US8603768B2 (en) | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
| WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
| EP2299904B1 (en) | 2008-06-06 | 2019-09-11 | Intuity Medical, Inc. | Medical measurement method |
| US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
| US8551320B2 (en) * | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
| US9184490B2 (en) | 2009-05-29 | 2015-11-10 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
| KR101100620B1 (en) * | 2009-06-04 | 2012-01-03 | 주식회사 인포피아 | Apparatus and method for bio-test with algorithm for improving reproducibility |
| US20100332445A1 (en) * | 2009-06-30 | 2010-12-30 | Lifescan, Inc. | Analyte testing method and system |
| EP2455875A3 (en) * | 2009-06-30 | 2013-01-16 | Lifescan Scotland Limited | System and method for diabetes management |
| CA2957078C (en) * | 2009-06-30 | 2019-04-30 | Lifescan, Inc | Analyte testing methods and device for calculating basal insulin therapy |
| US9868974B2 (en) | 2009-07-27 | 2018-01-16 | SureSensors Ltd. | Sensor devices |
| US8346496B1 (en) | 2009-08-27 | 2013-01-01 | Wildcat Disocovery Technologies, Inc | Apparatus and method for multi-channel materials assaying |
| US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
| WO2011026148A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
| WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
| JP5657678B2 (en) * | 2009-09-29 | 2015-01-21 | ライフスキャン・スコットランド・リミテッドＬｉｆｅＳｃａｎ Ｓｃｏｔｌａｎｄ， Ｌｔｄ． | Analyte testing method and device for diabetes management |
| EP3106871B1 (en) | 2009-11-30 | 2021-10-27 | Intuity Medical, Inc. | A method of verifying the accuracy of the operation of an analyte monitoring device |
| US8877034B2 (en) | 2009-12-30 | 2014-11-04 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
| US8101065B2 (en) * | 2009-12-30 | 2012-01-24 | Lifescan, Inc. | Systems, devices, and methods for improving accuracy of biosensors using fill time |
| US8844725B2 (en) * | 2010-01-20 | 2014-09-30 | Roche Diagnostics Operations, Inc. | Test strip container with strip retainer and methods of manufacturing and utilization thereof |
| CN102802522B (en) | 2010-02-25 | 2015-12-09 | 生命扫描苏格兰有限公司 | There is analyte testing method and the system of insulin administration safety warning |
| EP2590098B1 (en) * | 2010-02-25 | 2014-11-05 | Lifescan Scotland Limited | Analyte testing method and system with high and low blood glucose trends notification |
| US20110208435A1 (en) * | 2010-02-25 | 2011-08-25 | Lifescan Scotland Ltd. | Capacitance detection in electrochemical assays |
| CA2791120A1 (en) | 2010-02-25 | 2011-09-01 | Lifescan Scotland Limited | Capacitance detection in electrochemical assay |
| US8742773B2 (en) | 2010-02-25 | 2014-06-03 | Lifescan Scotland Limited | Capacitance detection in electrochemical assay with improved response |
| US8773106B2 (en) | 2010-02-25 | 2014-07-08 | Lifescan Scotland Limited | Capacitance detection in electrochemical assay with improved sampling time offset |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8394343B2 (en) | 2010-04-27 | 2013-03-12 | Roche Diagnostics Operations, Inc. | Integrated test strip container with retaining insert |
| US20110278321A1 (en) | 2010-05-11 | 2011-11-17 | Roche Diagnostics Operations, Inc. | Hermetically sealed test strip container |
| CA2803797A1 (en) | 2010-06-25 | 2011-12-29 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
| BR112013000084A2 (en) | 2010-06-30 | 2020-09-29 | Lifescan Scotland Limited | method, system and device to ensure statistical power for mean pre- and postprandial glucose difference messages |
| AU2011287420B2 (en) | 2010-08-02 | 2015-05-07 | Cilag Gmbh International | Systems and methods for improved accuracy for temperature correction of glucose results for control solution |
| US8603323B2 (en) | 2010-09-20 | 2013-12-10 | Lifescan, Inc. | Apparatus and process for improved measurements of a monitoring device |
| US8932445B2 (en) | 2010-09-30 | 2015-01-13 | Cilag Gmbh International | Systems and methods for improved stability of electrochemical sensors |
| US8617370B2 (en) | 2010-09-30 | 2013-12-31 | Cilag Gmbh International | Systems and methods of discriminating between a control sample and a test fluid using capacitance |
| US20130229288A1 (en) | 2010-11-15 | 2013-09-05 | Lifescan Scotland Limited | Server-side initiated communication with analyte meter-side completed data transfer |
| US8349612B2 (en) | 2010-11-15 | 2013-01-08 | Roche Diagnostics Operations, Inc. | Guided structured testing kit |
| US9632054B2 (en) | 2010-12-31 | 2017-04-25 | Cilag Gmbh International | Systems and methods for high accuracy analyte measurement |
| EP2661617B1 (en) * | 2011-01-05 | 2018-03-21 | Microchip Technology Incorporated | Glucose measurement using a current source |
| US8956518B2 (en) | 2011-04-20 | 2015-02-17 | Lifescan, Inc. | Electrochemical sensors with carrier field |
| ES2672726T3 (en) * | 2011-05-27 | 2018-06-15 | Lifescan Scotland Limited | Peak compensation correction for analyte test strip |
| EP3407064B1 (en) | 2011-08-03 | 2020-04-22 | Intuity Medical, Inc. | Body fluid sampling arrangement |
| US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
| US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| RU2488104C1 (en) * | 2012-01-27 | 2013-07-20 | Анатолий Иванович Мамаев | Method for determination of electrical characteristics and/or identification of biological objects and apparatus for realising said method |
| RU2014143774A (en) | 2012-03-30 | 2016-05-27 | Лайфскэн Скотлэнд Лимитед | METHOD AND SYSTEM FOR DETERMINING AND STORING THE BATTERY STATUS IN MEDICAL MONITORING |
| CA2884065C (en) | 2012-09-07 | 2020-01-07 | Cilag Gmbh International | Electrochemical sensors and a method for their manufacture |
| US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
| US9080196B2 (en) | 2012-09-28 | 2015-07-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US9005426B2 (en) | 2012-09-28 | 2015-04-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US8926369B2 (en) | 2012-12-20 | 2015-01-06 | Lifescan Scotland Limited | Electrical connector for substrate having conductive tracks |
| US8858884B2 (en) | 2013-03-15 | 2014-10-14 | American Sterilizer Company | Coupled enzyme-based method for electronic monitoring of biological indicator |
| US9121050B2 (en) | 2013-03-15 | 2015-09-01 | American Sterilizer Company | Non-enzyme based detection method for electronic monitoring of biological indicator |
| US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
| US9435764B2 (en) | 2013-06-27 | 2016-09-06 | Lifescan Scotland Limited | Transient signal error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9435762B2 (en) | 2013-06-27 | 2016-09-06 | Lifescan Scotland Limited | Fill error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9835578B2 (en) | 2013-06-27 | 2017-12-05 | Lifescan Scotland Limited | Temperature compensation for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| US9828621B2 (en) | 2013-09-10 | 2017-11-28 | Lifescan Scotland Limited | Anomalous signal error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte |
| US9291593B2 (en) | 2013-11-22 | 2016-03-22 | Cilag Gmbh International | Dual-chamber analytical test strip |
| JP6321968B2 (en) * | 2014-01-17 | 2018-05-09 | 株式会社Ｓｏｋｅｎ | Gas sensor element |
| US20160091451A1 (en) | 2014-09-25 | 2016-03-31 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip to determine analyte measurement time based on measured temperature, physical characteristic and estimated analyte value |
| US20160091450A1 (en) | 2014-09-25 | 2016-03-31 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip to determine analyte measurement time based on measured temperature, physical characteristic and estimated analyte value and their temperature compensated values |
| CN106290530B (en) * | 2016-08-31 | 2018-10-30 | 微泰医疗器械(杭州)有限公司 | It is a kind of can self-correction interference signal electrochemical analyte sensor-based system and method |
| RU2698526C1 (en) * | 2018-09-03 | 2019-08-28 | Максим Юрьевич Дидик | Method for measuring current pulse charging |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE148387C (en) | 1902-06-24 | 1904-02-16 | ||
| DE208230C (en) | 1908-04-05 | 1909-03-20 | ||
| JPS5912135B2 (en) | 1977-09-28 | 1984-03-21 | 松下電器産業株式会社 | enzyme electrode |
| DE3278334D1 (en) | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
| JPS59195149A (en) * | 1983-04-20 | 1984-11-06 | Fuji Electric Co Ltd | Measuring method |
| JPS59204755A (en) * | 1983-05-09 | 1984-11-20 | Fuji Electric Co Ltd | Measurement of amylase in urine |
| JPS629265A (en) * | 1985-07-05 | 1987-01-17 | Fuji Electric Co Ltd | Measuring instrument utilizing immobilized enzyme membrane |
| GB2201248B (en) * | 1987-02-24 | 1991-04-17 | Ici Plc | Enzyme electrode sensors |
| US4940945A (en) | 1987-11-02 | 1990-07-10 | Biologix Inc. | Interface circuit for use in a portable blood chemistry measuring apparatus |
| JPH0820412B2 (en) | 1990-07-20 | 1996-03-04 | 松下電器産業株式会社 | Quantitative analysis method and device using disposable sensor |
| US5352351A (en) * | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US5366609A (en) * | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| JPH07113783A (en) * | 1993-10-20 | 1995-05-02 | Daikin Ind Ltd | Concentration measuring method and device thereof |
| AUPN661995A0 (en) * | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| JPH09274010A (en) * | 1996-04-04 | 1997-10-21 | Matsushita Electric Ind Co Ltd | Determination method for substrate |
| JPH09318587A (en) * | 1996-05-31 | 1997-12-12 | Oji Paper Co Ltd | Measurement of concentration of substance |
| JP2000162176A (en) * | 1998-09-22 | 2000-06-16 | Omron Corp | Measuring method and measuring device using biosensor |
| JP4590943B2 (en) * | 2004-06-14 | 2010-12-01 | ソニー株式会社 | Content playback device |
| JP4940945B2 (en) * | 2006-12-29 | 2012-05-30 | ブラザー工業株式会社 | Liquid ejection device |
-
1999
- 1999-06-15 US US09/333,793 patent/US6193873B1/en not_active Expired - Lifetime
-
2000
- 2000-06-12 IL IL13670000A patent/IL136700A/en not_active IP Right Cessation
- 2000-06-13 CA CA002311431A patent/CA2311431C/en not_active Expired - Lifetime
- 2000-06-14 RU RU2000115708A patent/RU2238548C2/en active
- 2000-06-14 ES ES00305037T patent/ES2212969T3/en not_active Expired - Lifetime
- 2000-06-14 AT AT00305037T patent/ATE256869T1/en active
- 2000-06-14 AR ARP000102927A patent/AR024351A1/en active IP Right Grant
- 2000-06-14 PT PT00305037T patent/PT1067384E/en unknown
- 2000-06-14 NO NO20003045A patent/NO20003045L/en not_active Application Discontinuation
- 2000-06-14 EP EP00305037A patent/EP1067384B1/en not_active Expired - Lifetime
- 2000-06-14 DE DE60007229T patent/DE60007229T2/en not_active Expired - Lifetime
- 2000-06-14 SG SG200003363A patent/SG80681A1/en unknown
- 2000-06-14 MY MYPI20002702A patent/MY126044A/en unknown
- 2000-06-14 DK DK00305037T patent/DK1067384T3/en active
- 2000-06-15 BR BRPI0002963-7 patent/BRPI0002963B8/en unknown
- 2000-06-15 AU AU40868/00A patent/AU761438B2/en not_active Expired
- 2000-06-15 HU HU0002275A patent/HUP0002275A3/en unknown
- 2000-06-15 CN CNB001227203A patent/CN1160563C/en not_active Expired - Lifetime
- 2000-06-15 JP JP2000179706A patent/JP4573400B2/en not_active Expired - Lifetime
- 2000-06-15 KR KR1020000032952A patent/KR100712380B1/en active IP Right Grant
- 2000-06-16 ID IDP20000494D patent/ID26387A/en unknown
- 2000-08-25 TW TW089111668A patent/TW510970B/en not_active IP Right Cessation
-
2001
- 2001-05-04 HK HK01103170A patent/HK1032820A1/en not_active IP Right Cessation
- 2001-07-07 HK HK01104678A patent/HK1034314A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2311431C (en) | Sample detection to initiate timing of an electrochemical assay | |
| US20200348306A1 (en) | Slope-Based Compensation | |
| CA2649644C (en) | Underfill detection system for an electrochemical biosensor | |
| US10724985B2 (en) | Biosensor for determining a concentration of a biosensor using an underfill procedure | |
| CN1296704C (en) | Timing passive sample test | |
| US9234866B2 (en) | Underfill recognition biosensor | |
| US10690614B2 (en) | Method of using an electrochemical test sensor | |
| MXPA00005876A (en) | Sample detection to initiate timing of an electrochemical assay |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20200613 |